<DOC>
	<DOCNO>NCT01358383</DOCNO>
	<brief_summary>This assessment Pharmacokinetics single oral dose VIMOVO healthy adult volunteer .</brief_summary>
	<brief_title>Assessment Pharmacokinetics Single Oral Dose VIMOVO Healthy Adult Volunteers</brief_title>
	<detailed_description>A Phase I , Open-label , Single-center Study Assess Pharmacokinetics Single Oral Dose VIMOVO ( 250 mg Naproxen/20 mg Esomeprazole ) Healthy Adult Subjects</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Healthy male female subject age 18 55 year Capable understanding comply Clinical Study Protocol Body mass index ( BMI ) 19 30 kg/m2 weight 50 100 kg Previous enrollment present study Receipt another investigational product within 4 week study plan participate another study time study Female subject positive urine pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Juvenile Idiopathic Arthritis</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>VIMOVO</keyword>
	<keyword>fast state</keyword>
	<keyword>Amount VIMOVO blood</keyword>
	<keyword>take empty stomach</keyword>
</DOC>